Table 1 Features and groupings of 510 patients with DLBCL
Features | Instances (N) |
|---|---|
Age | ≤ 60 (288), > 60 (222) |
Sex | Male (262), Female (248) |
Stage | I (50), II (179), III (87), IV (194) |
IPI | Low (255), Low-intermediate (102), High-intermediate (101), High (52) |
KPS | ≥ 80 (419), < 80 (91) |
WBC | Low (100), Normal (377), High (33) |
LDH | Normal (389), High (121) |
β2-MG | Normal (373), High (137) |
ESR | Normal (321), High (189) |
GCB | Yes (302), No (208) |
CD10 | Negative (339), Positive (171) |
Bcl-6 | Negative (87), Positive (423) |
MUM-1 | Negative (276), Positive (234) |
Ki-67 | <  50 (53), 50 ~ 80 (165), > 80 (292) |
Rituximab | Not use (290), Use (220) |
Relapse | No (329), Yes (181) |